Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein

Blood

Volumn 96, Issue 4, 2000, Pages 1206-1214

  Kelly, Patrick F ^a   Vandergriff, Jody ^a   Nathwani, Amit ^a   Nienhuis, Arthur W ^a   Vanin, Elio F ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL POPULATION; COMBINED IMMUNODEFICIENCY; GENE EXPRESSION; GENE TRANSFER; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SCID MOUSE; STEM CELL; UMBILICAL CORD BLOOD; VIRUS PARTICLE;

EID: 0034663147     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.4.1206     Document Type: Article

References (60)

1. Prospects for human gene therapy
2. The hematopoietic system as a target for gene therapy
3. In vivo selection of retrovirally transduced hematopoietic stem cells
4. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer
5. Use of the green fluorescent protein gene as a marker to identify and track genetically modified hematopoietic cells
6. + cells
7. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation
8. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor
9. Efficient transduction by an amphotropic retrovirus vector is dependent on high-level expression of the cell surface virus receptor
10. The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction
11. Gene transfer by retrovirus vectors occurs only in ceils that are actively replicating at the time of infection
12. Engraftment of immunedeficient mice with human hematopoietic stem cells
13. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice
14. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice
15. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy
16. High-efficiency gene transfer and expression in normal human hematopoietic cells with retrovirus vectors
17. High-efficiency gene transfer to human hematopoietic cells maintained in long-term marrow culture
18. Gene transfer into normal human hematopoietic cells using in vitro and in vivo assays
19. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture
20. Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture
21. A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family
22. Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus
23. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters
24. Improved transfer of the leukocyte integrin CD18 subunit into hematopoietic cell lines by using retroviral vectors having a gibbon ape leukemia virus envelope
25. Highly efficient transduction of the green fluorescent protein gene in human umbilical cord blood stem cells capable of cobblestone formation in long-term cultures and multilineage engraftment of immunodeficient mice
26. +38 low primitive cells capable of reconstituting long-term cultures in vitro and nonobese diabetic-severe combined immunodeficiency mice in vivo
27. Identification of human and mouse hematopoietic stem cell populations expressing high levels of mRNA encoding retrovirus receptors
28. Gene transfer into marrow repopulating cells: Comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons
29. High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum-free conditions
30. Optimization of retroviral-mediated gene transfer to human NOD/SCID mouse repopulating cord blood cells through a systematic analysis of protocol variables
31. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential
32. - cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: Dissociation of SRC phenotype and function
33. A defined window for efficient gene marking of severe combined immunodeficient-repopulating cells using a gibbon ape leukemia virus-pseudotyped retroviral vector
34. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability
35. + cells
36. Retroviral marking of canine bone marrow: Long-term, high-level expression of human interleukin-2 receptor common gamma chain in canine lymphocytes
37. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein
38. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus
39. Pseudotyped retroviral vectors for studies of human gene therapy
40. + cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G
41. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
42. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells
43. One-day ex vivo culture allows effective gene transfer into human nonobese diabetic/severe combined immune-deficient repopulating cells using high-titer vesicular stomatitis virus G protein pseudotyped retrovirus
44. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors
45. Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors
46. The RD114/simian type D retrovirus receptor is a neutral amino acid transporter
47. Receptor interference groups of 20 retroviruses plating on human cells
48. High-titer packaging cells producing recombinant retroviruses resistant to human serum
49. A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells
50. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene
51. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus
52. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes
53. Factors affecting retroviral vector function and structural integrity
54. Characterization of replication competent retroviruses from nonhuman primates with virus induced T-cell lymphomas and observations regarding the mechanism of oncogenesis
55. Retroviral-fibronectin interaction in transduction of mammalian cells
56. Human CD38: A cell surface protein with multiple functions
57. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha
58. Involvement of retinoic acid receptor-α-mediated signaling pathway in induction of CD38 cell-surface antigen
59. - cell transduction via lentivirus-based gene transfer vectors
60. Envelope-binding domain in the cationic amino acid transporter determines the host range of ecotropic murine retroviruses